Biotech entity
fda-approval is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention 23andMe, the most common co-covered peer. Each carries 7 original sources on average. We currently track 1 Biotech story that mention Threat Actor (unidentified), all published on July 19, 2026.
Last mentioned: Jul 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
fda-approval is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention 23andMe, the most common co-covered peer. Each carries 7 original sources on average. We currently track 1 Biotech story that mention Threat Actor (unidentified), all published on July 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Threat Actor (unidentified). Shared-story counts are live from our verified record — not editorial picks.
The $18 million settlement over 6.9 million exposed genetic profiles sends a shockwave through the biotech sector. It underscores how consumer genomics data—once a research treasure trove—can become a career-ending liability when security fails.
Source: greeleytribune.com · broomfieldenterprise.com
Threat Actor (unidentified) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
